Tvm Life Science Ventures Vii L.p. - Net Worth and Insider Trading

Tvm Life Science Ventures Vii L.p. Net Worth

The estimated net worth of Tvm Life Science Ventures Vii L.p. is at least $1 Million dollars as of 2024-05-06. Tvm Life Science Ventures Vii L.p. is the Director, 10% Owner of Acer Therapeutics Inc and owns about 1,697,709 shares of Acer Therapeutics Inc (ACER) stock worth over $1 Million. Details can be seen in Tvm Life Science Ventures Vii L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tvm Life Science Ventures Vii L.p. has not made any transactions after 2018-08-01 and currently still holds the listed stock(s).

Transaction Summary of Tvm Life Science Ventures Vii L.p.

To

Tvm Life Science Ventures Vii L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tvm Life Science Ventures Vii L.p. owns 2 companies in total, including Acer Therapeutics Inc (ACER) , and CoLucid Pharmaceuticals Inc (CLCD) .

Click here to see the complete history of Tvm Life Science Ventures Vii L.p.’s form 4 insider trades.

Insider Ownership Summary of Tvm Life Science Ventures Vii L.p.

Ticker Comapny Transaction Date Type of Owner
ACER Acer Therapeutics Inc 2018-08-01 director & 10 percent owner
CLCD CoLucid Pharmaceuticals Inc 2017-03-01 10 percent owner

Tvm Life Science Ventures Vii L.p. Latest Holdings Summary

Tvm Life Science Ventures Vii L.p. currently owns a total of 1 stock. Tvm Life Science Ventures Vii L.p. owns 1,697,709 shares of Acer Therapeutics Inc (ACER) as of August 1, 2018, with a value of $1 Million.

Latest Holdings of Tvm Life Science Ventures Vii L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACER Acer Therapeutics Inc 2018-08-01 1,697,709 0.66 1,120,658

Holding Weightings of Tvm Life Science Ventures Vii L.p.


Tvm Life Science Ventures Vii L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Tvm Life Science Ventures Vii L.p. has made a total of 0 transactions in Acer Therapeutics Inc (ACER) over the past 5 years. The most-recent trade in Acer Therapeutics Inc is the acquisition of 275,000 shares on August 1, 2018, which cost Tvm Life Science Ventures Vii L.p. around $5 Million.

Insider Trading History of Tvm Life Science Ventures Vii L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tvm Life Science Ventures Vii L.p. Trading Performance

GuruFocus tracks the stock performance after each of Tvm Life Science Ventures Vii L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tvm Life Science Ventures Vii L.p. is 19.3%. GuruFocus also compares Tvm Life Science Ventures Vii L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Tvm Life Science Ventures Vii L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tvm Life Science Ventures Vii L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tvm Life Science Ventures Vii L.p.

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 50.68
Relative Return to S&P 500(%) 47.55

Tvm Life Science Ventures Vii L.p. Ownership Network

Ownership Network List of Tvm Life Science Ventures Vii L.p.

No Data

Ownership Network Relation of Tvm Life Science Ventures Vii L.p.


Tvm Life Science Ventures Vii L.p. Owned Company Details

What does Acer Therapeutics Inc do?

Who are the key executives at Acer Therapeutics Inc?

Tvm Life Science Ventures Vii L.p. is the director & 10 percent owner of Acer Therapeutics Inc. Other key executives at Acer Therapeutics Inc include director & President and Chief Executive Chris Schelling , Chief Operating Officer Tanya Hayden , and Chief Medical Officer Adrian W Quartel .

Acer Therapeutics Inc (ACER) Insider Trades Summary

Over the past 18 months, Tvm Life Science Ventures Vii L.p. made no insider transaction in Acer Therapeutics Inc (ACER). Other recent insider transactions involving Acer Therapeutics Inc (ACER) include a net purchase of 819,672 shares made by Chris Schelling , and a net purchase of 409,836 shares made by Steve Aselage .

In summary, during the past 3 months, insiders sold 0 shares of Acer Therapeutics Inc (ACER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acer Therapeutics Inc (ACER) were sold and 1,229,508 shares were bought by its insiders, resulting in a net purchase of 1,229,508 shares.

Acer Therapeutics Inc (ACER)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acer Therapeutics Inc Insider Transactions

No Available Data

Tvm Life Science Ventures Vii L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Tvm Life Science Ventures Vii L.p.. You might contact Tvm Life Science Ventures Vii L.p. via mailing address: 204, Rue Notre-dame Ouest, Bureau 350, Montreal A8 H2y 1t3.

Discussions on Tvm Life Science Ventures Vii L.p.

No discussions yet.